Macquarie Group LTD Vericel Corp Transaction History

Macquarie Group LTD

$80.3 Billion
Q1 2025

A detailed history of Macquarie Group LTD transactions in Vericel Corp stock. As of the latest transaction made, Macquarie Group LTD holds 662,904 shares of VCEL stock, worth $26.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

662,904

Previous 923,199 28.19%

Holding current value

$26.8 Million

Previous $50.7 Million 41.65%

% of portfolio

0.04%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$44.5 - $61.8 $11.6 Million - $16.1 Million	-260,295 Reduced 28.19%	662,904 $29.6 Million
Q4 2024 Feb 14, 2025	SELL	$40.05 - $59.11 $560,820 - $827,717	-14,003 Reduced 1.49%	923,199 $50.7 Million
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $2.95 Million - $3.73 Million	-69,726 Reduced 6.92%	937,202 $39.6 Million
Q2 2024 Aug 09, 2024	SELL	$41.71 - $52.9 $3.16 Million - $4.01 Million	-75,768 Reduced 7.0%	1,006,928 $46.2 Million
Q1 2024 May 14, 2024	SELL	$32.52 - $52.33 $2.06 Million - $3.32 Million	-63,497 Reduced 5.54%	1,082,696 $56.3 Million
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $863,306 - $1.04 Million	-27,984 Reduced 2.38%	1,146,193 $40.8 Million
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $1.1 Million - $1.36 Million	-34,565 Reduced 2.86%	1,174,177 $39.4 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $1.88 Million - $2.48 Million	64,666 Added 5.65%	1,208,742 $45.4 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $1.86 Million - $2.45 Million	78,158 Added 7.33%	1,144,076 $33.5 Million
Q4 2022 Feb 21, 2023	SELL	$17.65 - $27.37 $3.17 Million - $4.92 Million	-179,658 Reduced 14.42%	1,065,918 $28.1 Million
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $6.73 Million - $9.68 Million	-297,614 Reduced 19.29%	1,245,576 $28.9 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $450,392 - $776,573	19,685 Added 1.29%	1,543,190 $38.9 Million
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $12.6 Million - $17.3 Million	-398,775 Reduced 20.74%	1,523,505 $58.2 Million
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $10.2 Million - $15.3 Million	-289,929 Reduced 13.11%	1,922,280 $75.5 Million
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $11.1 Million - $14.3 Million	239,905 Added 12.16%	2,212,209 $108 Million
Q2 2021 Aug 13, 2021	BUY	$47.2 - $67.81 $93 Million - $134 Million	1,970,774 Added 128808.76%	1,972,304 $104 Million
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $29,259 - $56,268	-946 Reduced 38.21%	1,530 $85,000
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $16,677 - $28,350	900 Added 57.11%	2,476 $77,000
Q2 2020 Aug 11, 2020	BUY	$8.5 - $15.82 $13,396 - $24,932	1,576 New	1,576 $22,000
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $11,361 - $14,203	-700 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$10.77 - $18.44 $4,308 - $7,376	-400 Reduced 36.36%	700 $12,000
Q3 2018 Nov 15, 2018	SELL	$9.1 - $14.8 $45,500 - $74,000	-5,000 Reduced 81.97%	1,100 $16,000
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $58,560 - $89,060	6,100 New	6,100 $59,000
Q1 2018 May 11, 2018	SELL	$5.7 - $12.3 $10,260 - $22,140	-1,800 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$3.65 - $5.98 $6,570 - $10,764	1,800	1,800 $10,000

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

52.1M

Call Options Held

36.7K

Put Options Held

6.4K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.91B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Vericel Corp Transaction History